Sitemap Innovation Overview Capabilities Innovation is Pipeline Drug discovery Clinical studies Clinical studies at UCB: How are medicines made and tested? FAQ Glossary Current studies Clinical studies index Data Transparency Policy Publications Funding Grants Investigator-Initiated Studies Solutions Overview Empowering Decisions for Women of Childbearing Age Healthcare professionals Immune to the impossible Women of childbearing age Clinical guidelines Pregnancy and lactation studies Podcasts Rheumacensus Diseases Neurology Immunology Axial Spondyloarthritis Dravet syndrome Epilepsy Hidradenitis Suppurativa Lennox-Gastaut syndrome Lupus Myasthenia Gravis (MG) Osteoporosis Parkinson's disease Psoriasis Psoriatic arthritis Rheumatoid arthritis Thymidine Kinase deficiency type 2 Medicines About UCB Overview Management Sustainability Environmental Sustainability Health of the planet - CO2e Green packaging Conserving water Reducing waste UCB Materiality Update Results Equitable Access Patient Engagement Health, Safety and Wellbeing Diversity, Equity, and Inclusion Our positions Ethics & Business Integrity Collaborate with us Partnering Suppliers Requisition to Pay Process Become our supplier Responsible Procurement at UCB Newsroom Overview Press releases Our stories Resources Contact details Investors Overview Equity Story Performance Corporate governance Shareholders Shareholders meeting 2024 Shareholders meeting 2023 Shareholders meeting 2022 Shareholders meeting 2021 Shareholders meeting 2020 Shareholders meeting 2019 Shareholders meeting 2018 Shareholders meeting 2017 Transparency notifications Notification Art. 74 Share repurchase program UCB Analyst Contacts Download center Footer Contact us UCB Cares UCB Worldwide Legal Notice Privacy policies Cookie policies Cookie preferences Payment disclosure Sitemap
